CAR-T Cost in Thailand

Many hospitals across the country offer CAR-T to international patients. Some of the most renowned hospitals for CAR-T in Thailand include the following:

1. Bangpakok 9 International Hospital (BPK 9)

A. After discharge from the hospital, the patient has to stay for another 30 days in the country for complete recovery. During this time, the patient undergoes medical tests and consultations. this is to ensure that the treatment was successful and the patient is safe to return.

The length of recovery following CAR-T cell therapy varies based on a patient's unique circumstances, such as their general health and treatment response. Patients may need to stay in the hospital for monitoring for a maximum of seven to fourteen days, while some may need longer.

It may take from weeks to months for a patient to fully recover, and others may require continuous care due to adverse effects. Although the procedure might be comparable in Thailand, it's essential to speak with a local healthcare professional for advice tailored to your particular situation.

A. There are certain additional costs that the patient has to pay apart from the CAR-T cost. The per day cost in this case may start from USD 50 per person.

A. Some of the popular cities in Thailand that offer CAR-T include the following:

• Bangkok
• Krabi

A. Patients who are interested in availing of telemedicine consultation before they travel for CAR-T in Thailand can opt for the same. Many CAR-T surgeons offer video telemedicine consultation, including the following:

After CAR-T, the patient is supposed to stay for about 2 days in the hospital for recovery and monitoring. The patient is subjected to several biochemistry and radiological scans to see that everything is okay and the recovery is on track. After making sure that the patient is clinically stable, discharge is planned.

A. There are more than 1 hospitals that offer CAR-T in Thailand. These clinics have propoer infrastructure as well as offer good quality services when it comes to CAR-T These hospitals comply with all the rules and regulations as dictated by the regulatory bodies and medical associations in Thailand

A. Some of the renowned doctors for CAR-T in Thailand are:

1. Dr. Adisorn Boonyapiban
2. Dr. Benjawan Limpwanaspong
3. Dr. Wichit Arpornwirat

A. CAR-T's success rate in Thailand depends on factors such as the patient population and substance use. CAR-T therapy has remarkable results, specifically for hematological malignancies such as Acute Lymphoblastic Leukemia (ALL) and a few types of lymphoma.

The CAR-T response can vary between forty to eighty percent in a clinical setting which is dependent on the. This therapy is relatively novel and evolving and has not been publicized yet. It is advised to consult a healthcare professional before undergoing CAR-T.

A. Yes, international patients may be eligible for CAR-T treatment in Thailand. CAR-T treatment can be obtained throughout Thailand at several healthcare facilities that are ready to treat foreign patients. Such clinics can offer assistance when it comes to transportation, accommodation, and further management and, usually, might have experience working with foreigners.

If one is to consider this particular approach then one should contact the specific medical facility to find out their procedures, qualification criteria, and any fees associated with the process.

Specifically designed for blood cancer, AR T-cell therapy is a tailored cancer treatment modality. Blood from the patient will be used to create T-cells that will be transformed into chimeric antigen receptors (CAR) in a lab. T-cells can identify a particular kind of malignancy because of their modified antigen receptors.

Upon being reintroduced into the cancer patient's body, CAR T-cells will eradicate the specific cancer cells. Additionally, CAR T-cells will steadily multiply, remain in the body, suppress cancer cells, and stop cancer from returning.

CAR-T cells can be used to treat the following:

• B-cell acute lymphoblastic leukemia
• B-cell non-Hodgkin's lymphoma
• Mantle cell lymphoma, Follicular lymphoma
• Multiple myeloma
• Other blood cancer types

A. Some patients may need CAR T-cell therapy since their childhood cancer has relapsed. It can also be applied in managing refractory (R/R) blood malignancies that do not respond to conventional therapies; such as acute lymphoblastic leukemia (ALL), Large B cell non-Hodgkin’s lymphoma, and solid tumors- neuroblastoma.

It may be helpful to talk to a pediatric oncologist who will assess whether or not you are suitable for CAR T-cell therapy due to your state of health. These include the type of cancer, the stage of the cancer, the previous treatments that have been given, and overall health. One should contact a pediatric oncologist for consultation and recommendations.

A. CAR T-cell treatment is referred to as "living medications." As the name suggests, T cells are the foundation of CAR T-cell treatment since they assist in coordinating the immune system's response and eliminating pathogen-infected cells. The CAR T-cell treatments that are now available are personalized for each patient.

1. Initial assessments take 1 to 2 weeks including reviewing the medical history, imaging, and blood tests.
2. The first step in the therapy procedure is to remove the patient's T cells and re-engineer them in a lab to create proteins known as chimeric antigen receptors, or CARs, which attach to and recognize particular proteins, or antigens, on the surface of cancer cells. This process takes 2 to 4 weeks to complete.
3. The preparation for infusion takes 3 to 5 days. T cells will undergo transformation, be cultivated to a million copies in the lab, and then be returned to the patient. Infusion is usually done within a day
4. As CAR T cells proliferate within the body, they will use their modified receptor to identify and eliminate cancer cells present on the surface of the targeted antigens.
5. The overall procedure for CAR-T is usually completed in 4 to 8 weeks but this can vary based on the patient’s condition and the facility providing the therapy.

A. Yes, clinical studies utilizing CAR-T treatment are accessible in Thailand. Numerous medical facilities and academic establishments across the nation are engaged in continuous investigations aimed at assessing the effectiveness and safety of CAR-T therapies for various cancer types.

A. While CAR T-cell therapy has demonstrated remarkable efficacy in treating certain tumors that are difficult to treat, it can occasionally result in severe or even fatal side effects.

• Cytokine release syndrome (CRS): As CAR T cells proliferate, they may discharge copious quantities of substances known as cytokines into the bloodstream, thereby enhancing the immune system. This release may cause serious adverse effects, which include:
• Chills and a high fever
• Breathing difficulties
• Severe diarrhea, vomiting, or nausea
• Feeling lightheaded or vertigo
• Headaches
• Rapid heart rate
• Exhaustion.
• Joint and/or muscle aches
• Nervous system issues: This medication may occasionally have detrimental effects on the nervous system, which may cause symptoms like:
• Headaches
• Alterations in awareness
• Bewilderment or agitation
• Convulsions
• trembling, swaying, or twitching
• Difficulty understanding and communicating
• Imbalance loss

The following are other major negative effects of CAR T-cell treatment that may occur:

• Reactions to allergens during infusion
• Abnormal blood mineral levels, such as low levels of phosphorus, potassium, or sodium
• A compromised immune system and a higher chance of dangerous infections
• Low blood cell counts, which raise the possibility of infections, exhaustion, and bleeding or bruises

A. Yes, a customized treatment plan is usually involved with CAR-T therapy in Thailand. The procedure is customized for each patient and consists of the following:

1. Pre-Treatment Assessment: A thorough assessment that takes into account imaging, diagnostic testing, and medical history is necessary to decide which course of action is best.
2. Personalized CAR-T Cells: Your treatment is extremely customized since the T cells taken from your blood are genetically altered to specifically target your cancer kind.
3. Monitoring and Follow-Up: Following the infusion, patients are closely watched, and the course of treatment is modified by each patient's unique needs and any side effects.

The goal of this individualized strategy is to improve patient outcomes and therapy efficacy. Talking through these details with your medical team will help you better understand how CAR-T therapy will be customized for you.

A. Indeed, depending on the individual circumstances of the patient and the type of cancer being treated, CAR-T therapy can be used in combination with other cancer treatments in Thailand. Common combinations could consist of:

• Chemotherapy: To prepare their immune systems for CAR-T infusion, some patients go through a conditioning course of chemotherapy.
• Immunotherapy: By combining CAR-T with additional immunotherapies, overall efficacy may be increased.
• Radiation therapy: Before or after CAR-T therapy, certain cancers may be targeted with radiation.
• Targeted Therapies: These may be combined with other treatments to address particular features of cancer.

Always speak with your medical team to determine the best course of action for your particular illness. They can shed light on the advantages and disadvantages of combining different therapies.